Aurora Auto-Flowering Research Set To Transform Cannabis Cultivation In High-Latitude Regions

Zinger Key Points
  • Aurora Cannabis Inc. is innovating its operations via research in auto-flowering technology.
  • Auto-flowering technology doesn’t have to rely on changes in light cycles.
  • The company efforts have resulted in improved potency and yield, thereby driving down cost per gram and increasing overall efficiency.

Canadian medical cannabis company Aurora Cannabis Inc. ACB ACB is innovating its operations via research in auto-flowering technology.

The company said the innovative work provides foundational insight into the flowering mechanism in cannabis. The research would support future breeding strategies. It also could be utilized to advance outdoor cannabis cultivation in high-latitude regions, such as Canada.

Aurora has received a US Patent 12,002,546, “Methods of Determining Sensitivity to Photoperiod in Cannabis”, allowing for its breeding program to identify and select for the auto-flowering trait.

What Is Auto-Flowering?

Having a genetic characteristic to automatically transition the plant from the vegetative stage to the flowering stage the auto-flowering technology doesn't have to rely on changes in light cycles.

Read Also: What Are Autoflowering, Feminized And Regular Cannabis Seeds?

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

Jose Celedon, PhD, director of breeding and genetics at Aurora, praised the company's research efforts.

“As a company backed by science, we have long invested in research both independently and with leading academic institutions, and have achieved significant learning from our work,” Celedon said. “Our recent work on auto-flowering will be a game-changer for cannabis and hemp production.

Aurora’s research and innovation efforts have resulted in improved potency and yield, thereby driving down cost per gram and increasing overall efficiency.

In the meantime, Aurora recently teamed up with Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, to launch the newly developed Luo CBD lozenge. The product was developed by Vectura Fertin Pharma and represents Aurora's first medical cannabis CBD lozenge to be introduced in Canada.

Read Next:

Price Action: Aurora's shares traded 4.07% lower at $5.66 per share during the pre-market session on Tuesday morning.

Image: Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsEducationautofloweringCannabis Cultivationcannabis innovationCannabis ResearchCCCJose Celedon
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.